In the bestselling tradition of Jeffrey Archer and Dick Francis comes a hot new commercial talent.
A young scientist, Cameron, has an idea which could revolutionise medicine. She believes that, once published, her findings will change the world.
A maverick financier, Bryn, sees the potential, but convinces her that truth alone is never what secures change: it’s money, nous and competitive savvy.
He persuades her to go into business with him. Their aim: to build a stockmarket company worth a hundred million pounds — big enough to survive assault; strong enough to market Cameron’s technology to the entire world.
Corinth, a corporation worth a hundred billion dollars, sees Cameron’s technology as a threat and aims to wipe out the fledgling enterprise.
The story becomes a race to the stockmarket — and a battle to survive.
